UBE2R2 and central nervous system cancer: Zhou and his group identified a set of six lncRNAs (XLOC_004803, AC073115.6, RP11-89C21.2, ENTPD1-AS1, UBE2R2-AS1, and AC005013.5) which can be used as a novel marker for glioma patients.